Berlin – Parenteral Drug Association Europe (PDA EU) is hosting its 10th Parenteral Packaging Conference in Basel, Switzerland, 25-26 February. The conference features presentations and discussions by industry leaders and technical experts from pharma and supplier companies. This year’s event includes expert discussions on the EU’s Medical Device Regulation 117 and on closed system transfer devices.
Stephanie Goebel, TÜV Süd Germany, will give the notified body perspective of EU MDR 117 and its impact on combination products during the opening session of the conference.
Closed systems transfer devices is the topic for breakout Track A. It features talks by a host of experts. Cathy Zhao, West, will discuss guidance on interconnectability of vial container closure systems and vial transfer devices. Zhao recently published an article in the PDA Letter titled, “Five Challenges of Closed System Transfer Devices,” which delves into the U.S. Pharmacopeia <800> Hazardous Drugs—Handling in Healthcare Settings, which went into effect on 1 Dec 2019.
Track B focuses on of the meeting focuses on packaging considerations for deep cold and cryogenic storage. This track includes three presentations on the challenges related particularly to cell and gene therapy products.
Other tracks will address container-closure integrity, glass, drug product-packaging interaction, sterilization and decontamination challenges, and the impact of new technologies and digitalization.
For the complete agenda, go to https://www.pda.org/global-event-calendar/event-detail/parenteral-packaging#overview
Press passes are available for conferences and workshops to bona fide members of the press: https://www.pda.org/about-pda/press-pass-request-form.